Physician profile
William James Thomas
NPI 1245246263
$2,099.01
in general payments reported to CMS, 2019-2025
15 companies · $128 in 2025
The $128 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $442 · 2021: $229 · 2022: $565 · 2023: $386 · 2024: $349 · 2025: $128.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $863.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $863.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genentech USA, INC. | $529.57 | 2019-2023 | Vabysmo, Lucentis |
| Alcon Vision LLC | $268.42 | 2022-2025 | Constellation, Tryptyr |
| Novartis Pharmaceuticals Corporation | $212.97 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $211.07 | 2022-2024 | Eylea Hd |
| Astellas Pharma US INC | $166.87 | 2023-2024 | Izervay |
| Apellis Pharmaceuticals, INC. | $152.49 | 2022-2025 | Syfovre |
| Allergan, INC. | $141.63 | 2019-2021 | |
| Biotissue Holdings INC. | $92.72 | 2022 | |
| Bausch & Lomb Americas INC. | $78.66 | 2023-2024 | Xipere, Xiidra |
| Janssen Scientific Affairs, LLC | $76.50 | 2019 | |
| Biogen, INC. | $56.00 | 2022-2023 | |
| Abbvie INC. | $55.27 | 2025 | |
| Spark Therapeutics, INC. | $19.80 | 2021 | |
| Sun Pharmaceutical Industries INC. | $19.22 | 2025 | |
| Genentech, INC. | $17.82 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw William Thomas listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.